Ireland· IE-PA-EU/1/98/066/027-030
Exelon 13.3 mg/24 h transdermal patch
A rivastigmine product containing rivastigmine, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 18 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Rivastigmine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06DA03 (rivastigmine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 11 of them publish a price we can compare per daily dose
Rivastigmine · ATC N06DA03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rivastigmine costs, country by country.
Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.042 in Czechia to $2.19 in Italy — a ×52 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rivastigmine · price per daily dose (9 mg)
USD · FX 28 Sept 2026
- IT Italy$2.19
- CH Switzerland$1.33
- CZ Czechia$0.042
The record
At a glance
HPRA (Ireland)- Active substance
- Rivastigmine
- Manufacturer
- Novartis Europharm Limited
- Country
- Ireland (IE)
- ATC code
- N06DA03
- ATC class
- Rivastigmine
- Defined daily dose
- 9 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/98/066/027-030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
235 interactions on record for rivastigmine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rivastigmine · interactions on record
235 records
- 8 severe
- 166 moderate
- 59 info
Most severe, free to view
- OzanimodL04AA38severe
- SiponimodL04AA42severe
- OzanimodL04AE02severe
- SiponimodL04AE03severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rivastigmine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALZERTA 13,3 MG/24 H PARCHES TRANSDERMICOS EFGEsteve Pharmaceuticals S.A.
- CzechiaEXELONNovartis Europharm Limited, Dublin
- United StatesExelonSandoz Inc
- BelgiumExelon 13.3 mg/24 hNovartis Europharm
- PolandEvertasZentiva, k.s.
- FinlandRivastigmin Ratiopharmratiopharm GmbH
- SwitzerlandRivastigmin Patch Sandoz eco 13,3 mg/24 h (23,1 mg), transdermale PflasterSandoz Pharmaceuticals AG
- ItalyDEMELORANEURAXPHARM ITALY S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Nimgista, Rivagelan
- Belgium · Rivastigmin Sandoz, Rivastigmine Viatris
- Bulgaria · Ридаксин
- Germany · Demelora, Rivastigmin
- Denmark · Rigmin, Rivastigmin Orion
- Spain · Alzerta, Alzerta Dos Por Semana
- Finland · Rivastigmin Orion, Rivastigmine Sandoz
- France · Rivastigmine Arrow, Rivastigmine Biogaran
- United Kingdom (Northern Ireland) · Almuriva, Alzest
- Greece · Alapril, Balaxon
- Iceland · Exelon, Nimvastid
- Italy · Demelora, Rivastigmina Aurobindo
- Liechtenstein · Exelon, Rivastigmine 1 A Pharma
- Malta · Rivastigmine Aurobindo
- Netherlands · Ristidic, Rivastgimine Neuraxpharm
- Norway · Exelon, Nimvastid
- Poland · Atmina, Evertas
- Portugal · Nervopan, Rivastigmina Alter
- Romania · Evertas, Ridaxin
- Sweden · Rigmin, Rivastigmin Orion
- Slovenia · Rivastigmin Teva, Rivastigmin Teva B.V.
- Slovakia · Ristidic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b608e792-3ec0-4662-bf04-44e07e1b0b28 GET /v1/drugs/b608e792-3ec0-4662-bf04-44e07e1b0b28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Transdermal patch",
"routes": [
"Transdermal use"
],
"source": "hpra",
"atc_all": [
"N06DA",
"N06DA03"
],
"strength": null,
"pa_number": "EU/1/98/066/027-030",
"substances": [
"Rivastigmine"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": "IC0159-198-068"
}See everything about rivastigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.